Serum level of soluble interleukin 6 receptor is a useful biomarker for identification of treatment‐resistant major depressive disorder

AIM: A substantial proportion of major depressive disorder patients are treatment‐resistant to antidepressant therapy, who require augmentation drugs, or other treatments including electroconvulsive therapy or transcranial magnetic stimulation. Identifying treatment‐resistant major depressive disord...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamasaki, Katsuhiko, Hasegawa, Tomonori, Takeda, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722658/
https://www.ncbi.nlm.nih.gov/pubmed/32162496
http://dx.doi.org/10.1002/npr2.12100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722658/
https://www.ncbi.nlm.nih.gov/pubmed/32162496
http://dx.doi.org/10.1002/npr2.12100

Ejemplares similares